Regular paper
Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities

https://doi.org/10.1016/0014-2999(95)00069-WGet rights and content

Abstract

The potencies for in vivo inhibition of substantia nigra pars compacta dopamine single cell firing were determined for apomorphine, BHT 920, N-0923, (±)-7-hydroxy-dipropylaminotetralin (7-OH-DPAT), (+)-3-(3-hydroxyphenyl)-N-propylpiperidine (3-PPP), pramipexole, quinelorane, quinpirole, RU 24926, U-86170, and U-91356. Significant correlation was obtained between the potencies of these 11 highly efficacious dopamine receptor agonists and the in vitro binding affinities at dopamine D3 receptors, but not at dopamine D2L receptors. These results support a functional role for the dopamine D3 receptor subtype in the autoreceptor-mediated regulation of dopamine cell activity, while a role for dopamine D2 receptors awaits further analysis. In addition, the results demonstrate the limitations of using currently available dopamine receptor agonists to delineate relative in vivo roles for the dopamine D2 and D3 receptor subtypes.

Cited by (81)

  • Development of MCM-41 mesoporous silica nanoparticles as a platform for pramipexole delivery

    2019, Journal of Drug Delivery Science and Technology
    Citation Excerpt :

    Neurodegenerative diseases, such as Parkinson's disease (PD) are great challenge from diagnostic and therapeutic point of view, thus alternatives and improvements to the current therapies are demanding. Pramipexole (2-amino-4,5,6,7-tetrahydro-6-propylamino-benzethiazole-dihydrochloride) is a third-generation full intrinsic dopamine receptor agonist with a nonergot structure [1]. It has been successfully used for the symptomatic treatment of early and advanced Parkinson's disease (PD), either alone or in combination with levodopa [2,3].

  • An endogenous dopaminergic tone acting on dopamine D <inf>3</inf> receptors may be involved in diurnal changes of tuberoinfundibular dopaminergic neuron activity and prolactin secretion in estrogen-primed ovariectomized rats

    2012, Brain Research Bulletin
    Citation Excerpt :

    Both synthesis and release of DA, and membrane excitability are decreased by activation of autoreceptors [31]. In addition to D2 receptors, D3 receptors have also been shown playing a role as autoreceptors [12,13,16,37]. On the other hand, the identity of autoreceptors in hypothalamic TIDA neurons (A12) has been controversial as mentioned in the Introduction.

  • Toxicity assessment of pramipexole in juvenile rhesus monkeys

    2010, Toxicology
    Citation Excerpt :

    Pramipexole (PPX) is a non-ergot dopamine agonist with high relative in vitro specificity and full intrinsic activity at the D2 subfamily of dopamine (DA) receptors, binding with higher affinity to D3 than to D2 or D4 receptor subtypes (Kreiss et al., 1995; Mierau et al., 1995).

  • Dopaminergic control of food choice: Contrasting effects of SKF 38393 and quinpirole on high-palatability food preference in the rat

    2006, Neuropharmacology
    Citation Excerpt :

    These data are consistent with neurochemical findings which identify a connection between ingestion of high-palatability foods, including sucrose solutions, and enhanced levels of extracellular dopamine in the nucleus accumbens (Hajnal and Norgren, 2001; Hajnal et al., 2004; Martel and Fantino, 1996a,b). Quinpirole, like other dopamine D2/D3 receptor agonists, inhibits cell firing in the substantia nigra (Kreiss et al., 1995), and inhibits dopamine release at dopaminergic terminals (Kennedy et al., 1992) while also regulating the activity of the dopamine transporter (Zapata and Shippenberg, 2002). These drugs reduce dopamine levels in the shell and core compartments of the nucleus accumbens in freely moving rats (Shilliam and Heidbreder, 2003).

  • Regulation of dense core vesicle release from PC12 cells by interaction between the D2 dopamine receptor and calcium-dependent activator protein for secretion (CAPS)

    2005, Biochemical Pharmacology
    Citation Excerpt :

    It will clearly be of interest to determine whether the CAPS/D2 interaction has a similar effect on dopamine secretion in neurons. A further issue that should be raised in this context is that D3 receptors have also been localized to presynaptic terminals where they are also believed to function as inhibitory autoreceptors [34,35]. Our protein interaction screens and coimmunoprecipitation experiments failed to uncover an interaction between CAPS and D3 receptors.

View all citing articles on Scopus
1

Current address: Pharmacology Unit, Dept. Physiology & Pharmacology, School of Medicine, University of Cantabria, Cardena Herrera Oria St., 39011 Santander, Cantabria, Spain.

View full text